DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE

DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE was reported 41905 times

DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATAPLEXY 175 0.1235
1 PRE-EXISTING CONDITION IMPROVED 679 0.1087
2 PRODUCT ADMINISTRATION INTERRUPTED 658 0.0837
3 ASTHMA EXERCISE INDUCED 25 0.0718
4 SLEEP-RELATED EATING DISORDER 62 0.0662
5 PERIODIC LIMB MOVEMENT DISORDER 24 0.0652
6 SLEEP PARALYSIS 94 0.0640
7 NARCOLEPSY 115 0.0609
8 MANUFACTURING ISSUE 28 0.0602
9 PERINATAL DEPRESSION 25 0.0554
10 PARASOMNIA 37 0.0515
11 ABNORMAL SLEEP-RELATED EVENT 66 0.0500
12 SLEEP ATTACKS 23 0.0483
13 EHLERS-DANLOS SYNDROME 22 0.0473
14 ATTENTION DEFICIT HYPERACTIVITY DISORDER 198 0.0470
15 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 61 0.0452
16 SOMNAMBULISM 291 0.0443
17 ENURESIS 178 0.0440
18 SUBSTANCE USE 67 0.0429
19 SNORING 158 0.0418
20 OBSTRUCTIVE SLEEP APNOEA SYNDROME 60 0.0411
21 AMPHETAMINES POSITIVE 29 0.0387
22 DISSOCIATION 278 0.0362
23 JOB DISSATISFACTION 23 0.0354
24 SLEEP APNOEA SYNDROME 649 0.0340
25 INABILITY TO AFFORD MEDICATION 313 0.0315
26 TERMINAL INSOMNIA 55 0.0310
27 HANGOVER 108 0.0307
28 PRODUCT TAMPERING 52 0.0289
29 THYROTOXIC CRISIS 32 0.0281
30 PRODUCT AVAILABILITY ISSUE 617 0.0271
31 SUDDEN ONSET OF SLEEP 37 0.0267
32 SLEEP TALKING 44 0.0259
33 POST-TRAUMATIC STRESS DISORDER 171 0.0255
34 THERAPEUTIC PRODUCT EFFECT VARIABLE 97 0.0250
35 TACHYPHRENIA 86 0.0248
36 GENERALISED ANXIETY DISORDER 36 0.0245
37 BINGE EATING 26 0.0241
38 FEELING DRUNK 178 0.0239
39 DRUG TOLERANCE 118 0.0233
40 DRUG EFFECT VARIABLE 26 0.0229
41 MOANING 26 0.0228
42 INSURANCE ISSUE 329 0.0215
43 INITIAL INSOMNIA 220 0.0214
44 MAST CELL ACTIVATION SYNDROME 30 0.0214
45 CLAUSTROPHOBIA 23 0.0211
46 DISTRACTIBILITY 23 0.0199
47 EDUCATIONAL PROBLEM 33 0.0198
48 GAMBLING DISORDER 53 0.0196
49 MAJOR DEPRESSION 140 0.0191
50 ABNORMAL UTERINE BLEEDING 49 0.0191
51 PRESCRIBED OVERDOSE 369 0.0191
52 BIPOLAR DISORDER 207 0.0190
53 COMPLEX REGIONAL PAIN SYNDROME 28 0.0189
54 BRUXISM 99 0.0183
55 IMPULSIVE BEHAVIOUR 67 0.0178
56 GASTRIC BYPASS 38 0.0175
57 TIC 95 0.0174
58 LIBIDO INCREASED 35 0.0172
59 BRAIN FOG 270 0.0172
60 MOTION SICKNESS 33 0.0171
61 NASAL SEPTUM DEVIATION 33 0.0169
62 DRUG DIVERSION 104 0.0168
63 MENTAL FATIGUE 25 0.0167
64 DISTURBANCE IN ATTENTION 897 0.0166
65 SLEEP DEFICIT 35 0.0165
66 DRUG SCREEN NEGATIVE 27 0.0153
67 PRODUCT SUBSTITUTION ISSUE 872 0.0151
68 OBSESSIVE-COMPULSIVE DISORDER 120 0.0149
69 COMPULSIVE SHOPPING 30 0.0146
70 ALCOHOL ABUSE 39 0.0146
71 CERVICAL SPINAL STENOSIS 25 0.0145
72 ENDOMETRIOSIS 69 0.0145
73 SEDATION 378 0.0144
74 SUSPECTED PRODUCT QUALITY ISSUE 26 0.0142
75 THERAPEUTIC RESPONSE UNEXPECTED 635 0.0141
76 SEIZURE LIKE PHENOMENA 24 0.0141
77 BIPOLAR I DISORDER 31 0.0141
78 PRODUCT PHYSICAL ISSUE 281 0.0139
79 HUNGER 194 0.0139
80 DRUG TITRATION ERROR 35 0.0135
81 CRANIOCEREBRAL INJURY 41 0.0135
82 BACTERIAL VAGINOSIS 21 0.0134
83 FEELING JITTERY 255 0.0134
84 RESTLESS LEGS SYNDROME 242 0.0133
85 MENOPAUSE 34 0.0132
86 EMOTIONAL POVERTY 23 0.0131
87 PARANOIA 226 0.0131
88 SLEEP TERROR 54 0.0128
89 HYPOPNOEA 44 0.0127
90 LYME DISEASE 42 0.0126
91 HYSTERECTOMY 109 0.0126
92 ESSENTIAL HYPERTENSION 23 0.0126
93 AUTOIMMUNE THYROIDITIS 47 0.0124
94 NOCTURIA 150 0.0123
95 AUTONOMIC NERVOUS SYSTEM IMBALANCE 36 0.0123
96 DRUG EFFECT LESS THAN EXPECTED 178 0.0120
97 LOGORRHOEA 42 0.0119
98 SURGERY 688 0.0117
99 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 24 0.0116
100 POOR QUALITY SLEEP 248 0.0115
101 CONCUSSION 89 0.0115
102 MIDDLE INSOMNIA 213 0.0114
103 FRUSTRATION TOLERANCE DECREASED 92 0.0114
104 PANIC DISORDER 44 0.0113
105 DENTAL CARE 21 0.0113
106 LOSS OF EMPLOYMENT 34 0.0112
107 APATHY 164 0.0112
108 HYPERTONIC BLADDER 32 0.0111
109 ANGER 373 0.0110
110 PHYSICAL ASSAULT 23 0.0110
111 SHOULDER OPERATION 47 0.0110
112 INTENTIONAL DOSE OMISSION 312 0.0109
113 AFFECTIVE DISORDER 86 0.0109
114 HORMONE LEVEL ABNORMAL 53 0.0109
115 FOREIGN BODY IN REPRODUCTIVE TRACT 96 0.0107
116 PANIC ATTACK 391 0.0107
117 DISTURBANCE IN SOCIAL BEHAVIOUR 25 0.0106
118 TEMPOROMANDIBULAR JOINT SYNDROME 28 0.0105
119 VITAMIN D DEFICIENCY 102 0.0104
120 PULSE ABNORMAL 25 0.0104
121 EUPHORIC MOOD 106 0.0103
122 IRRITABILITY 621 0.0103
123 NECK SURGERY 24 0.0103
124 PRODUCT FORMULATION ISSUE 68 0.0103
125 MIGRAINE WITH AURA 28 0.0103
126 FEELING OF DESPAIR 48 0.0103
127 ENDODONTIC PROCEDURE 26 0.0102
128 DENTAL OPERATION 25 0.0101
129 THINKING ABNORMAL 186 0.0100
130 INTERVERTEBRAL DISC DEGENERATION 92 0.0099
131 EYE CONTUSION 21 0.0099
132 SUICIDAL IDEATION 907 0.0099
133 CLUMSINESS 27 0.0099
134 SPINAL FUSION SURGERY 40 0.0098
135 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 22 0.0098
136 UNEVALUABLE EVENT 732 0.0097
137 SEASONAL ALLERGY 136 0.0096
138 ANORGASMIA 26 0.0096
139 NECK INJURY 28 0.0095
140 FLAT AFFECT 22 0.0095
141 DEPRESSION 2150 0.0094
142 ORAL SURGERY 22 0.0094
143 PRODUCT TASTE ABNORMAL 127 0.0094
144 YAWNING 25 0.0094
145 DISABILITY 183 0.0092
146 VITAMIN D DECREASED 79 0.0092
147 CRYING 331 0.0091
148 FIBROMYALGIA 220 0.0090
149 ANXIETY 2546 0.0089
150 MIGRAINE 852 0.0089
151 MOOD SWINGS 284 0.0089
152 OBESITY 141 0.0088
153 EMOTIONAL DISORDER 271 0.0088
154 DYSPAREUNIA 40 0.0087
155 SOMNOLENCE 1743 0.0086
156 ANGLE CLOSURE GLAUCOMA 22 0.0086
157 DENTAL CARIES 95 0.0086
158 MANIA 141 0.0086
159 DRUG EFFECT INCREASED 27 0.0085
160 CARTILAGE INJURY 21 0.0085
161 FEELING ABNORMAL 2034 0.0085
162 FOOT OPERATION 42 0.0085
163 SPINAL STENOSIS 35 0.0085
164 MUSCLE TIGHTNESS 137 0.0084
165 REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE 30 0.0084
166 PERSONALITY CHANGE 78 0.0084
167 EMBEDDED DEVICE 83 0.0084
168 PSYCHOMOTOR HYPERACTIVITY 139 0.0084
169 RADICULOPATHY 22 0.0083
170 ACNE CYSTIC 25 0.0083
171 FOOD ALLERGY 64 0.0083
172 CARPAL TUNNEL SYNDROME 116 0.0083
173 ANIMAL BITE 22 0.0082
174 INFUSION SITE PRURITUS 26 0.0082
175 INTERVERTEBRAL DISC PROTRUSION 179 0.0082
176 PHARYNGITIS STREPTOCOCCAL 88 0.0081
177 IMPAIRED DRIVING ABILITY 92 0.0081
178 SCOLIOSIS 50 0.0081
179 PARANASAL SINUS DISCOMFORT 30 0.0079
180 HYPOMANIA 29 0.0079
181 DRUG SCREEN POSITIVE 62 0.0078
182 MENISCUS INJURY 48 0.0078
183 ABNORMAL BEHAVIOUR 309 0.0078
184 FOOD CRAVING 41 0.0078
185 HYPERPHAGIA 31 0.0078
186 IMPAIRED WORK ABILITY 166 0.0078
187 PLANTAR FASCIITIS 26 0.0077
188 SUBSTANCE ABUSE 63 0.0077
189 ALCOHOLISM 33 0.0077
190 NEURALGIA 187 0.0077
191 AFFECT LABILITY 74 0.0077
192 IMPAIRED GASTRIC EMPTYING 104 0.0076
193 GLUCOSE TOLERANCE IMPAIRED 45 0.0076
194 THERAPEUTIC RESPONSE CHANGED 48 0.0076
195 SLUGGISHNESS 77 0.0075
196 NEGATIVE THOUGHTS 22 0.0075
197 FEELING OF BODY TEMPERATURE CHANGE 44 0.0075
198 ELECTRIC SHOCK SENSATION 21 0.0075
199 INTENTIONAL PRODUCT USE ISSUE 657 0.0075
200 HYPERSOMNIA 214 0.0075
201 CEREBRAL DISORDER 55 0.0074
202 SOCIAL AVOIDANT BEHAVIOUR 43 0.0074
203 PSYCHOTIC DISORDER 219 0.0074
204 ROAD TRAFFIC ACCIDENT 310 0.0074
205 HOMICIDAL IDEATION 30 0.0074
206 MUSCLE TWITCHING 170 0.0074
207 IMPAIRED QUALITY OF LIFE 106 0.0074
208 COMPLICATION OF DEVICE REMOVAL 132 0.0073
209 PERFORMANCE STATUS DECREASED 34 0.0073
210 NEPHROLITHIASIS 333 0.0073
211 HALLUCINATION, AUDITORY 115 0.0072
212 DECREASED INTEREST 42 0.0071
213 KNEE OPERATION 70 0.0071
214 APNOEA 55 0.0071
215 BRADYPHRENIA 46 0.0070
216 APPENDICECTOMY 25 0.0070
217 ANAL INCONTINENCE 63 0.0070
218 HEREDITARY ANGIOEDEMA 75 0.0070
219 HYPERACUSIS 26 0.0070
220 DEVICE PLACEMENT ISSUE 25 0.0070
221 WITHDRAWAL SYNDROME 293 0.0070
222 MOOD ALTERED 190 0.0070
223 FACIAL BONES FRACTURE 25 0.0069
224 BACK INJURY 75 0.0069
225 TEMPERATURE INTOLERANCE 71 0.0069
226 BLOOD TESTOSTERONE DECREASED 47 0.0069
227 CHOLECYSTECTOMY 78 0.0068
228 NERVE COMPRESSION 63 0.0068
229 PRODUCT COLOUR ISSUE 35 0.0068
230 THERAPEUTIC RESPONSE SHORTENED 226 0.0068
231 LIGAMENT RUPTURE 30 0.0068
232 ENERGY INCREASED 40 0.0068
233 THYROID MASS 26 0.0068
234 THIRST 121 0.0068
235 PRODUCT SUPPLY ISSUE 48 0.0067
236 DYSMENORRHOEA 89 0.0067
237 SELF-INJURIOUS IDEATION 28 0.0067
238 VITAMIN B12 DEFICIENCY 27 0.0067
239 PANIC REACTION 48 0.0066
240 BRAIN INJURY 66 0.0066
241 MICTURITION URGENCY 75 0.0066
242 MEMORY IMPAIRMENT 902 0.0066
243 HEAVY MENSTRUAL BLEEDING 59 0.0066
244 COMPLICATION OF DEVICE INSERTION 130 0.0065
245 DEPRESSED MOOD 345 0.0065
246 OVERWEIGHT 35 0.0065
247 MALABSORPTION 34 0.0065
248 HEAD INJURY 206 0.0065
249 SPINAL OPERATION 80 0.0065
250 ABNORMAL DREAMS 179 0.0065
251 MENTAL DISORDER 282 0.0065
252 TRIGEMINAL NEURALGIA 26 0.0065
253 ANKLE FRACTURE 100 0.0065
254 EYE MOVEMENT DISORDER 44 0.0064
255 RESTLESSNESS 235 0.0064
256 HALLUCINATIONS, MIXED 27 0.0064
257 INCREASED APPETITE 122 0.0064
258 DYSPHEMIA 28 0.0064
259 OVARIAN CYST 63 0.0063
260 AUTOIMMUNE DISORDER 61 0.0063
261 PARADOXICAL DRUG REACTION 23 0.0062
262 MUSCLE SPASTICITY 76 0.0062
263 INSOMNIA 1642 0.0062
264 UTERINE LEIOMYOMA 45 0.0062
265 SKIN ABRASION 29 0.0061
266 MULTIPLE ALLERGIES 48 0.0061
267 SCREAMING 39 0.0061
268 POOR PERIPHERAL CIRCULATION 26 0.0061
269 THERAPY CHANGE 60 0.0061
270 ARTHROPOD BITE 45 0.0061
271 ACTIVITIES OF DAILY LIVING IMPAIRED 120 0.0061
272 SEXUAL DYSFUNCTION 71 0.0060
273 AGGRESSION 303 0.0060
274 SPINAL OSTEOARTHRITIS 53 0.0060
275 SEBORRHOEA 22 0.0060
276 DRUG EFFECT DELAYED 27 0.0059
277 GYNAECOMASTIA 184 0.0059
278 GASTROENTERITIS VIRAL 107 0.0059
279 RETCHING 126 0.0059
280 UTERINE PERFORATION 50 0.0059
281 NIGHT SWEATS 190 0.0059
282 TOOTH FRACTURE 65 0.0059
283 NIGHTMARE 204 0.0059
284 LIMB INJURY 160 0.0059
285 APPETITE DISORDER 39 0.0059
286 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 282 0.0059
287 PELVIC PAIN 106 0.0058
288 BACK DISORDER 94 0.0058
289 MUSCLE STRAIN 50 0.0058
290 LIGAMENT SPRAIN 57 0.0058
291 INFUSION SITE SWELLING 36 0.0057
292 SINUS DISORDER 113 0.0057
293 PSYCHIATRIC SYMPTOM 42 0.0057
294 ROTATOR CUFF SYNDROME 73 0.0057
295 FOOT FRACTURE 107 0.0056
296 NEURODERMATITIS 21 0.0056
297 PERONEAL NERVE PALSY 32 0.0056
298 PHARYNGEAL SWELLING 55 0.0056
299 DERMATITIS CONTACT 64 0.0056
300 NEUROLOGICAL SYMPTOM 32 0.0056
301 AGITATION 411 0.0056
302 VULVOVAGINAL MYCOTIC INFECTION 22 0.0056
303 UPPER-AIRWAY COUGH SYNDROME 46 0.0056
304 ROSACEA 26 0.0056
305 SINUSITIS 571 0.0056
306 HYPERHIDROSIS 714 0.0055
307 SUICIDAL BEHAVIOUR 23 0.0055
308 EAR INFECTION 147 0.0055
309 THERAPEUTIC PRODUCT EFFECT DELAYED 25 0.0055
310 IRRITABLE BOWEL SYNDROME 117 0.0055
311 ECONOMIC PROBLEM 82 0.0054
312 TOOTH ABSCESS 55 0.0054
313 TRIGGER FINGER 22 0.0054
314 COGNITIVE DISORDER 251 0.0054
315 DRY MOUTH 433 0.0053
316 PERIPHERAL COLDNESS 73 0.0053
317 TOOTH EXTRACTION 66 0.0053
318 GALACTORRHOEA 34 0.0053
319 MULTIPLE SCLEROSIS 253 0.0053
320 SLEEP DISORDER 368 0.0052
321 INCONTINENCE 55 0.0052
322 MULTIPLE SCLEROSIS RELAPSE 353 0.0051
323 BLADDER DISORDER 51 0.0051
324 HEART RATE INCREASED 508 0.0051
325 ILLNESS 526 0.0051
326 OPTIC NEURITIS 46 0.0051
327 JOINT INJURY 108 0.0051
328 TRISMUS 26 0.0050
329 STREPTOCOCCAL INFECTION 28 0.0050
330 FORMICATION 35 0.0050
331 THERAPEUTIC PRODUCT EFFECT DECREASED 225 0.0050
332 CENTRAL NERVOUS SYSTEM LESION 69 0.0050
333 ANHEDONIA 130 0.0049
334 COORDINATION ABNORMAL 69 0.0049
335 INCOHERENT 32 0.0049
336 HAND FRACTURE 35 0.0049
337 TENSION 30 0.0049
338 WEIGHT FLUCTUATION 51 0.0049
339 BLOOD PRESSURE INCREASED 745 0.0049
340 DIPLOPIA 126 0.0048
341 HEART RATE ABNORMAL 27 0.0048
342 METABOLIC DISORDER 28 0.0048
343 MENSTRUATION IRREGULAR 129 0.0048
344 EAR DISORDER 22 0.0048
345 BALANCE DISORDER 415 0.0048
346 ONYCHOMYCOSIS 21 0.0048
347 TOOTH INFECTION 63 0.0048
348 TOOTH DISORDER 106 0.0048
349 SENSATION OF FOREIGN BODY 40 0.0047
350 DYSPHORIA 24 0.0047
351 FEELING HOT 290 0.0047
352 AUTISM SPECTRUM DISORDER 26 0.0047
353 EXOSTOSIS 43 0.0047
354 DYSKINESIA 191 0.0047
355 DELUSION 73 0.0047
356 PALPITATIONS 550 0.0047
357 URINARY INCONTINENCE 139 0.0047
358 SKIN LACERATION 51 0.0047
359 KIDNEY INFECTION 92 0.0047
360 PRODUCT QUALITY ISSUE 636 0.0047
361 PRODUCT PREPARATION ERROR 96 0.0047
362 FOOD POISONING 25 0.0047
363 MENTAL IMPAIRMENT 113 0.0047
364 INTERMENSTRUAL BLEEDING 26 0.0046
365 NECK PAIN 260 0.0046
366 VAGINAL DISCHARGE 47 0.0046
367 DISORIENTATION 184 0.0046
368 ABNORMAL WEIGHT GAIN 57 0.0046
369 PROCEDURAL PAIN 128 0.0046
370 OSTEOPENIA 70 0.0046
371 URINE ODOUR ABNORMAL 27 0.0046
372 MUSCULOSKELETAL DISCOMFORT 79 0.0046
373 LETHARGY 264 0.0046
374 COELIAC DISEASE 45 0.0046
375 NERVE INJURY 51 0.0046
376 DRUG EFFECT DECREASED 247 0.0046
377 GASTROOESOPHAGEAL REFLUX DISEASE 367 0.0046
378 BLOOD CHOLESTEROL ABNORMAL 21 0.0045
379 MUSCLE SPASMS 834 0.0045
380 SCIATICA 72 0.0045
381 TREMOR 749 0.0045
382 AMENORRHOEA 79 0.0045
383 HAIR DISORDER 37 0.0045
384 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 319 0.0045
385 COLD SWEAT 79 0.0045
386 EAR DISCOMFORT 46 0.0045
387 FACIAL PAIN 40 0.0045
388 NERVOUSNESS 233 0.0045
389 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
390 ACCIDENT 53 0.0044
391 BEHAVIOUR DISORDER 24 0.0044
392 INFUSION SITE PAIN 57 0.0044
393 WRIST FRACTURE 53 0.0044
394 POLLAKIURIA 183 0.0044
395 SCAR 75 0.0044
396 ASTHENOPIA 24 0.0044
397 AMNESIA 284 0.0044
398 VERTIGO 266 0.0044
399 PHOTOPHOBIA 82 0.0044
400 RESPIRATION ABNORMAL 30 0.0043
401 CYST 54 0.0043
402 THYROID DISORDER 67 0.0043
403 WEIGHT INCREASED 973 0.0043
404 HYPERPROLACTINAEMIA 28 0.0043
405 HYPERVENTILATION 25 0.0043
406 HEADACHE 2700 0.0043
407 BLOOD PRESSURE ABNORMAL 85 0.0043
408 QUALITY OF LIFE DECREASED 57 0.0042
409 HEPATIC STEATOSIS 79 0.0042
410 FEAR 114 0.0042
411 WEIGHT DECREASED 1177 0.0042
412 SINUS HEADACHE 25 0.0042
413 FATIGUE 3271 0.0042
414 CATATONIA 22 0.0042
415 HYPOAESTHESIA 627 0.0042
416 CHOKING SENSATION 23 0.0042
417 JOINT DISLOCATION 44 0.0042
418 TARDIVE DYSKINESIA 117 0.0041
419 NYSTAGMUS 22 0.0041
420 LIMB DISCOMFORT 128 0.0041
421 RIB FRACTURE 85 0.0041
422 TREATMENT NONCOMPLIANCE 226 0.0041
423 BLEPHAROSPASM 26 0.0041
424 SENSORY DISTURBANCE 66 0.0041
425 MENSTRUAL DISORDER 34 0.0041
426 PARAESTHESIA 645 0.0041
427 SENSORY LOSS 33 0.0041
428 BLOOD CHOLESTEROL INCREASED 191 0.0041
429 BRONCHITIS 302 0.0041
430 HALLUCINATION 307 0.0041
431 PRESYNCOPE 99 0.0041
432 SINUS CONGESTION 55 0.0041
433 SEROTONIN SYNDROME 78 0.0041
434 PSYCHOLOGICAL TRAUMA 35 0.0041
435 CARDIAC MURMUR 35 0.0040
436 EATING DISORDER 86 0.0040
437 DEVICE BREAKAGE 163 0.0040
438 HEAD DISCOMFORT 71 0.0040
439 PRODUCT DISTRIBUTION ISSUE 37 0.0040
440 BREAST TENDERNESS 30 0.0040
441 TINNITUS 182 0.0040
442 APHASIA 119 0.0039
443 UPPER RESPIRATORY TRACT INFECTION 182 0.0039
444 DYSARTHRIA 148 0.0039
445 HYPERTENSION 831 0.0039
446 PRODUCT DOSE OMISSION ISSUE 1150 0.0039
447 DROOLING 27 0.0039
448 PREGNANCY WITH CONTRACEPTIVE DEVICE 35 0.0039
449 SEIZURE 450 0.0039
450 AKATHISIA 53 0.0039
451 PARAESTHESIA ORAL 56 0.0039
452 HIP SURGERY 21 0.0039
453 MENSTRUATION DELAYED 42 0.0039
454 IMMUNE SYSTEM DISORDER 51 0.0039
455 CARDIAC FLUTTER 25 0.0039
456 CONDITION AGGRAVATED 1175 0.0039
457 BLOOD POTASSIUM DECREASED 116 0.0039
458 THERAPEUTIC RESPONSE DECREASED 233 0.0038
459 NONSPECIFIC REACTION 21 0.0038
460 TOOTHACHE 69 0.0038
461 DECREASED ACTIVITY 41 0.0038
462 THERAPY CESSATION 195 0.0038
463 EXPOSURE DURING PREGNANCY 236 0.0038
464 BLOOD IRON DECREASED 45 0.0038
465 HYPOTHYROIDISM 121 0.0038
466 BOWEL MOVEMENT IRREGULARITY 29 0.0038
467 HIATUS HERNIA 49 0.0038
468 NAUSEA 2969 0.0037
469 NASOPHARYNGITIS 690 0.0037
470 HAIR TEXTURE ABNORMAL 50 0.0037
471 TONGUE DISORDER 27 0.0037
472 MOTOR DYSFUNCTION 38 0.0037
473 SPEECH DISORDER 195 0.0037
474 COMPLICATION ASSOCIATED WITH DEVICE 54 0.0037
475 SPINAL DISORDER 35 0.0037
476 GENERALISED TONIC-CLONIC SEIZURE 61 0.0037
477 PRODUCT DOSE OMISSION IN ERROR 104 0.0037
478 DRUG INEFFECTIVE 4838 0.0037
479 PRODUCT PREPARATION ISSUE 24 0.0037
480 SKIN INFECTION 41 0.0037
481 OCULAR DISCOMFORT 41 0.0036
482 PRODUCT USE ISSUE 685 0.0036
483 LOWER LIMB FRACTURE 70 0.0036
484 MOUTH SWELLING 21 0.0036
485 ARTHRITIS 284 0.0036
486 DIZZINESS 1792 0.0036
487 COVID-19 630 0.0036
488 ABDOMINAL DISCOMFORT 601 0.0036
489 HYPOAESTHESIA ORAL 54 0.0036
490 BEDRIDDEN 47 0.0036
491 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 724 0.0036
492 INJURY 251 0.0036
493 INTENTIONAL UNDERDOSE 26 0.0036
494 SUICIDE ATTEMPT 215 0.0035
495 DEVICE DISLOCATION 154 0.0035
496 LOSS OF CONSCIOUSNESS 453 0.0035
497 INFUSION SITE EXTRAVASATION 22 0.0035
498 LOCALISED INFECTION 85 0.0035
499 MATERNAL EXPOSURE BEFORE PREGNANCY 24 0.0035
500 FALL 1168 0.0035
501 DYSGRAPHIA 23 0.0035
502 ORAL HERPES 68 0.0035
503 ERECTILE DYSFUNCTION 89 0.0035
504 MENORRHAGIA 68 0.0035
505 MUSCULAR WEAKNESS 393 0.0035
506 HALLUCINATION, VISUAL 73 0.0035
507 MUSCLE DISORDER 28 0.0035
508 SCHIZOPHRENIA 42 0.0035
509 ACNE 262 0.0035
510 RESPIRATORY TRACT INFECTION 89 0.0034
511 VISION BLURRED 467 0.0034
512 PRODUCT DISPENSING ERROR 74 0.0034
513 EAR PAIN 66 0.0034
514 PRODUCT LABEL ISSUE 23 0.0034
515 THERMAL BURN 24 0.0034
516 NASAL DRYNESS 21 0.0033
517 PRODUCT ODOUR ABNORMAL 35 0.0033
518 ASTHMA 376 0.0033
519 LYMPHOEDEMA 23 0.0033
520 UPPER LIMB FRACTURE 66 0.0033
521 ADVERSE DRUG REACTION 297 0.0033
522 FEELING COLD 92 0.0033
523 STAPHYLOCOCCAL INFECTION 109 0.0033
524 BACK PAIN 767 0.0033
525 FURUNCLE 26 0.0033
526 BREAST MASS 22 0.0033
527 MYDRIASIS 42 0.0033
528 CANDIDA INFECTION 55 0.0033
529 INTENTIONAL PRODUCT MISUSE 285 0.0033
530 SENSITIVE SKIN 24 0.0032
531 HOT FLUSH 245 0.0032
532 OSTEOARTHRITIS 137 0.0032
533 CHOKING 63 0.0032
534 CONFUSIONAL STATE 521 0.0032
535 HAIR COLOUR CHANGES 40 0.0032
536 DRUG DISPENSING ERROR 49 0.0032
537 INFUSION SITE ERYTHEMA 27 0.0032
538 DERMATITIS ATOPIC 168 0.0032
539 TENDERNESS 33 0.0032
540 DRY EYE 158 0.0032
541 INCREASED TENDENCY TO BRUISE 29 0.0031
542 MOVEMENT DISORDER 101 0.0031
543 DYSPEPSIA 309 0.0031
544 DECREASED APPETITE 729 0.0031
545 CONTUSION 301 0.0031
546 LOSS OF LIBIDO 28 0.0031
547 METRORRHAGIA 53 0.0031
548 TENDONITIS 48 0.0031
549 DIZZINESS POSTURAL 30 0.0031
550 DRUG USE DISORDER 26 0.0031
551 IMMUNODEFICIENCY 46 0.0031
552 POST PROCEDURAL INFECTION 25 0.0031
553 POST PROCEDURAL COMPLICATION 59 0.0031
554 THERAPY INTERRUPTED 219 0.0031
555 NASAL CONGESTION 180 0.0031
556 DRY THROAT 31 0.0030
557 NEUROPATHY PERIPHERAL 290 0.0030
558 DISCOMFORT 186 0.0030
559 DYSTONIA 59 0.0030
560 GAIT DISTURBANCE 580 0.0030
561 RENAL PAIN 32 0.0030
562 HYPERLIPIDAEMIA 36 0.0030
563 EYE INFECTION 34 0.0030
564 FEEDING DISORDER 61 0.0030
565 FUNGAL INFECTION 100 0.0030
566 MUSCLE ATROPHY 38 0.0030
567 EMOTIONAL DISTRESS 363 0.0030
568 NO ADVERSE EVENT 543 0.0030
569 KNEE ARTHROPLASTY 63 0.0030
570 EYE DISCHARGE 31 0.0030
571 FLUSHING 303 0.0030
572 OROPHARYNGEAL PAIN 275 0.0030
573 DRUG ABUSE 247 0.0030
574 RESPIRATORY TRACT CONGESTION 47 0.0030
575 DRUG WITHDRAWAL SYNDROME 259 0.0029
576 ABDOMINAL PAIN UPPER 607 0.0029
577 PAIN 1805 0.0029
578 FACIAL PARALYSIS 25 0.0029
579 MADAROSIS 34 0.0029
580 HYPERAESTHESIA 24 0.0029
581 INTENTIONAL SELF-INJURY 59 0.0029
582 THROAT TIGHTNESS 79 0.0029
583 SKIN FISSURES 57 0.0029
584 INFLUENZA LIKE ILLNESS 240 0.0029
585 PAROSMIA 22 0.0029
586 GALLBLADDER DISORDER 52 0.0029
587 MALIGNANT MELANOMA 39 0.0029
588 GASTROINTESTINAL PAIN 32 0.0029
589 NASAL DISCOMFORT 23 0.0029
590 BODY HEIGHT DECREASED 31 0.0029
591 BLOOD MAGNESIUM DECREASED 25 0.0029
592 HERNIA 56 0.0029
593 RENAL CYST 23 0.0029
594 GASTROINTESTINAL DISORDER 259 0.0029
595 BLOOD TRIGLYCERIDES INCREASED 51 0.0029
596 DEHYDRATION 385 0.0029
597 BLOOD SODIUM DECREASED 54 0.0029
598 PARALYSIS 41 0.0029
599 DISEASE RECURRENCE 136 0.0029
600 PSORIATIC ARTHROPATHY 116 0.0029
601 TACHYCARDIA 253 0.0028
602 HYPOPHOSPHATAEMIA 21 0.0028
603 APHTHOUS ULCER 22 0.0028
604 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 511 0.0028
605 TENDON RUPTURE 35 0.0028
606 SKIN HAEMORRHAGE 42 0.0028
607 ABDOMINAL DISTENSION 295 0.0028
608 SUPRAVENTRICULAR TACHYCARDIA 27 0.0028
609 ANKYLOSING SPONDYLITIS 37 0.0028
610 DEVICE EXPULSION 182 0.0028
611 VENTRICULAR EXTRASYSTOLES 29 0.0028
612 VOMITING 1312 0.0028
613 VAGINAL HAEMORRHAGE 121 0.0028
614 VISUAL IMPAIRMENT 345 0.0028
615 HYPERSENSITIVITY 515 0.0028
616 HOSPITALISATION 426 0.0028
617 OROPHARYNGEAL DISCOMFORT 25 0.0028
618 SWELLING 259 0.0028
619 ULCER 44 0.0028
620 INFLUENZA 308 0.0028
621 BLOOD PRESSURE FLUCTUATION 66 0.0027
622 URINARY TRACT INFECTION 465 0.0027
623 MALAISE 1192 0.0027
624 EXTRA DOSE ADMINISTERED 110 0.0027
625 IRON DEFICIENCY ANAEMIA 25 0.0027
626 CELLULITIS 136 0.0027
627 ECZEMA 141 0.0027
628 HYPOKINESIA 39 0.0027
629 PULMONARY MASS 40 0.0027
630 ALOPECIA 524 0.0027
631 ORAL DISCOMFORT 37 0.0027
632 HYPOPHAGIA 68 0.0027
633 POOR QUALITY PRODUCT ADMINISTERED 28 0.0027
634 APHONIA 37 0.0026
635 SKIN SWELLING 23 0.0026
636 SPINAL PAIN 31 0.0026
637 ABORTION SPONTANEOUS 106 0.0026
638 URINARY RETENTION 88 0.0026
639 DYSSTASIA 77 0.0026
640 HIDRADENITIS 24 0.0026
641 DRUG DOSE OMISSION 435 0.0026
642 GRIP STRENGTH DECREASED 23 0.0026
643 NEOPLASM 30 0.0026
644 PERIPHERAL SWELLING 402 0.0026
645 TOOTH LOSS 54 0.0026
646 PREGNANCY 52 0.0026
647 MASS 36 0.0026
648 SCRATCH 27 0.0026
649 VITREOUS FLOATERS 25 0.0025
650 SNEEZING 57 0.0025
651 PRODUCT USE COMPLAINT 40 0.0025
652 CHEST DISCOMFORT 260 0.0025
653 CONSTIPATION 553 0.0025
654 HEART RATE DECREASED 89 0.0025
655 PNEUMOTHORAX 40 0.0025
656 GROIN PAIN 22 0.0025
657 DYSURIA 92 0.0025
658 PRODUCT DOSE OMISSION 163 0.0025
659 DYSPHAGIA 237 0.0025
660 SKIN DISORDER 83 0.0025
661 UNRESPONSIVE TO STIMULI 64 0.0025
662 DYSGEUSIA 184 0.0025
663 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 42 0.0025
664 OESOPHAGITIS 27 0.0025
665 MUSCULOSKELETAL DISORDER 47 0.0025
666 RHINORRHOEA 159 0.0025
667 MUSCULOSKELETAL CHEST PAIN 38 0.0025
668 GASTRIC DISORDER 83 0.0024
669 MUSCULOSKELETAL STIFFNESS 211 0.0024
670 TREATMENT FAILURE 199 0.0024
671 JOINT STIFFNESS 63 0.0024
672 PRODUCT PRESCRIBING ERROR 57 0.0024
673 VIRAL INFECTION 79 0.0024
674 BLOOD URINE PRESENT 45 0.0024
675 DRUG EFFECT INCOMPLETE 86 0.0024
676 THROAT IRRITATION 106 0.0024
677 EYELID PTOSIS 24 0.0024
678 PHOTOSENSITIVITY REACTION 39 0.0024
679 ATAXIA 28 0.0024
680 APPENDICITIS 22 0.0024
681 MYALGIA 400 0.0024
682 SKIN DISCOLOURATION 108 0.0023
683 HYPERTHYROIDISM 34 0.0023
684 FLANK PAIN 22 0.0023
685 CHEST PAIN 434 0.0023
686 MUSCLE RIGIDITY 28 0.0023
687 FLUID RETENTION 119 0.0023
688 EYE PAIN 132 0.0023
689 GAIT INABILITY 78 0.0023
690 LYMPHOCYTE COUNT DECREASED 41 0.0023
691 URTICARIA 387 0.0023
692 ASTHENIA 868 0.0023
693 RECALLED PRODUCT ADMINISTERED 22 0.0023
694 PRESCRIBED UNDERDOSE 46 0.0023
695 CYSTITIS 73 0.0023
696 LYMPHADENOPATHY 81 0.0023
697 EYE SWELLING 85 0.0023
698 PHARYNGEAL OEDEMA 35 0.0023
699 PAIN IN EXTREMITY 669 0.0023
700 FOOT DEFORMITY 25 0.0023
701 SINUS TACHYCARDIA 32 0.0023
702 INJECTION SITE URTICARIA 55 0.0022
703 OSTEOPOROSIS 92 0.0022
704 ARTHROPATHY 124 0.0022
705 HERPES ZOSTER 128 0.0022
706 BLOOD PRESSURE DECREASED 147 0.0022
707 SWELLING FACE 144 0.0022
708 ANOSMIA 32 0.0022
709 GASTRITIS 58 0.0022
710 DYSPHONIA 128 0.0022
711 ORAL PAIN 49 0.0022
712 CHILLS 255 0.0022
713 BURNING SENSATION 152 0.0022
714 DRUG DEPENDENCE 347 0.0022
715 THERAPY NON-RESPONDER 97 0.0022
716 HYPERTENSIVE CRISIS 24 0.0022
717 BREAST PAIN 23 0.0022
718 CLOSTRIDIUM DIFFICILE INFECTION 47 0.0022
719 DERMATITIS 45 0.0021
720 MOBILITY DECREASED 154 0.0021
721 BURSITIS 26 0.0021
722 REBOUND EFFECT 24 0.0021
723 DRUG INTOLERANCE 205 0.0021
724 DRY SKIN 283 0.0021
725 ERUCTATION 41 0.0021
726 SYNCOPE 212 0.0021
727 ARTHRALGIA 880 0.0021
728 HEPATIC ENZYME INCREASED 144 0.0021
729 INJECTION SITE MASS 78 0.0021
730 SCAB 24 0.0021
731 HAEMORRHOIDS 41 0.0021
732 SPINAL FRACTURE 42 0.0021
733 ADVERSE EVENT 193 0.0021
734 DIVERTICULITIS 58 0.0021
735 INJECTION SITE INDURATION 27 0.0021
736 SWOLLEN TONGUE 65 0.0021
737 SECRETION DISCHARGE 26 0.0021
738 ABSCESS 33 0.0021
739 EYE DISORDER 68 0.0021
740 PRODUCT PRESCRIBING ISSUE 45 0.0021
741 ADRENAL INSUFFICIENCY 25 0.0021
742 COUGH 575 0.0020
743 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 145 0.0020
744 INCORRECT PRODUCT ADMINISTRATION DURATION 44 0.0020
745 PRODUCT ADMINISTRATION ERROR 41 0.0020
746 HIP ARTHROPLASTY 31 0.0020
747 MUSCULOSKELETAL PAIN 106 0.0020
748 DIABETES MELLITUS 153 0.0020
749 SKIN LESION 55 0.0020
750 SYSTEMIC LUPUS ERYTHEMATOSUS 71 0.0020
751 INJECTION SITE REACTION 137 0.0020
752 INCORRECT DOSE ADMINISTERED 453 0.0020
753 ELECTROLYTE IMBALANCE 23 0.0020
754 PAIN IN JAW 56 0.0020
755 SKIN ULCER 51 0.0020
756 PAIN OF SKIN 53 0.0020
757 MALNUTRITION 22 0.0020
758 DEVICE DEPLOYMENT ISSUE 25 0.0020
759 SKIN EXFOLIATION 165 0.0020
760 EXPIRED PRODUCT ADMINISTERED 65 0.0020
761 PRURITUS 750 0.0019
762 CARDIOMEGALY 24 0.0019
763 CHROMATURIA 44 0.0019
764 GASTRIC ULCER 37 0.0019
765 ABDOMINAL PAIN LOWER 49 0.0019
766 CHOLECYSTITIS 23 0.0019
767 MENTAL STATUS CHANGES 53 0.0019
768 EYE IRRITATION 109 0.0019
769 NERVOUS SYSTEM DISORDER 59 0.0019
770 WHEEZING 112 0.0019
771 ADVERSE REACTION 25 0.0019
772 DRUG INTERACTION 298 0.0019
773 SKIN IRRITATION 86 0.0019
774 GLOMERULAR FILTRATION RATE DECREASED 23 0.0019
775 DYSPNOEA 1059 0.0019
776 GLAUCOMA 36 0.0019
777 PRODUCT ADHESION ISSUE 66 0.0018
778 ANAPHYLACTIC REACTION 102 0.0018
779 INTENTIONAL OVERDOSE 118 0.0018
780 PALLOR 50 0.0018
781 LIP SWELLING 61 0.0018
782 HEMIPARESIS 31 0.0018
783 CHOLELITHIASIS 60 0.0018
784 SYRINGE ISSUE 32 0.0018
785 RASH 796 0.0018
786 ORAL CANDIDIASIS 24 0.0018
787 CONTRAINDICATED PRODUCT ADMINISTERED 55 0.0018
788 HEART RATE IRREGULAR 41 0.0018
789 BODY TEMPERATURE INCREASED 37 0.0018
790 PRODUCT USE IN UNAPPROVED INDICATION 449 0.0018
791 ABDOMINAL PAIN 420 0.0018
792 RASH MACULAR 63 0.0018
793 FLATULENCE 102 0.0018
794 INJECTION SITE BRUISING 143 0.0018
795 INJECTION SITE SWELLING 137 0.0018
796 TYPE 2 DIABETES MELLITUS 60 0.0018
797 CHRONIC KIDNEY DISEASE 135 0.0018
798 BLINDNESS UNILATERAL 25 0.0018
799 DRUG PRESCRIBING ERROR 34 0.0018
800 SKIN BURNING SENSATION 126 0.0018
801 MACULAR DEGENERATION 21 0.0018
802 LACRIMATION INCREASED 53 0.0018
803 INFECTION 252 0.0017
804 IMPAIRED HEALING 57 0.0017
805 OFF LABEL USE 1517 0.0017
806 BASAL CELL CARCINOMA 27 0.0017
807 TASTE DISORDER 35 0.0017
808 BONE PAIN 101 0.0017
809 HAEMATOCRIT DECREASED 34 0.0017
810 OSTEOMYELITIS 31 0.0017
811 EPISTAXIS 128 0.0017
812 MULTIPLE FRACTURES 28 0.0017
813 PSORIASIS 222 0.0017
814 INFLAMMATION 87 0.0017
815 OEDEMA 91 0.0017
816 MATERNAL EXPOSURE DURING PREGNANCY 149 0.0017
817 DIARRHOEA 1076 0.0017
818 ORTHOSTATIC HYPOTENSION 29 0.0017
819 DEVICE ISSUE 149 0.0017
820 CYANOSIS 26 0.0017
821 GLOSSODYNIA 37 0.0017
822 RASH PAPULAR 37 0.0016
823 ILL-DEFINED DISORDER 100 0.0016
824 EYE PRURITUS 55 0.0016
825 APPLICATION SITE PAIN 36 0.0016
826 RENAL DISORDER 76 0.0016
827 RHEUMATOID ARTHRITIS 185 0.0016
828 INJECTION SITE PRURITUS 109 0.0016
829 JOINT SWELLING 196 0.0016
830 BLINDNESS 66 0.0016
831 PRODUCT COMPLAINT 41 0.0016
832 DEEP VEIN THROMBOSIS 105 0.0016
833 INJECTION SITE PAIN 494 0.0016
834 RED BLOOD CELL COUNT DECREASED 46 0.0016
835 BACTERIAL INFECTION 30 0.0016
836 AGEUSIA 40 0.0016
837 THROMBOSIS 129 0.0016
838 BLISTER 90 0.0016
839 BONE DISORDER 29 0.0016
840 LIVER FUNCTION TEST INCREASED 34 0.0016
841 MOUTH ULCERATION 33 0.0016
842 UNDERDOSE 113 0.0015
843 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 80 0.0015
844 ACCIDENTAL OVERDOSE 56 0.0015
845 PRODUCTIVE COUGH 73 0.0015
846 ERYTHEMA 314 0.0015
847 BLOOD GLUCOSE ABNORMAL 28 0.0015
848 WHITE BLOOD CELL COUNT INCREASED 58 0.0015
849 CATARACT 90 0.0015
850 DEVICE DEFECTIVE 26 0.0015
851 INJECTION SITE RASH 46 0.0015
852 DEPRESSED LEVEL OF CONSCIOUSNESS 59 0.0015
853 LOCAL SWELLING 26 0.0015
854 STOMATITIS 90 0.0015
855 INFUSION RELATED REACTION 98 0.0015
856 OVERDOSE 316 0.0015
857 INTESTINAL OBSTRUCTION 55 0.0015
858 WRONG TECHNIQUE IN DRUG USAGE PROCESS 53 0.0015
859 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 80 0.0015
860 OCULAR HYPERAEMIA 69 0.0015
861 PULMONARY EMBOLISM 138 0.0015
862 HAEMATOCHEZIA 80 0.0014
863 RASH ERYTHEMATOUS 69 0.0014
864 INJECTION SITE ERYTHEMA 179 0.0014
865 EXPOSURE VIA SKIN CONTACT 37 0.0014
866 LIVER INJURY 35 0.0014
867 COLITIS 54 0.0014
868 DEAFNESS 37 0.0014
869 PNEUMONIA 448 0.0014
870 LEUKOCYTOSIS 25 0.0014
871 NEEDLE ISSUE 40 0.0014
872 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 25 0.0014
873 LUNG INFECTION 21 0.0014
874 INCORRECT DRUG ADMINISTRATION DURATION 38 0.0013
875 HYPOKALAEMIA 62 0.0013
876 COLITIS ULCERATIVE 60 0.0013
877 HAEMATEMESIS 34 0.0013
878 TRANSIENT ISCHAEMIC ATTACK 45 0.0013
879 FREQUENT BOWEL MOVEMENTS 36 0.0013
880 RASH PRURITIC 72 0.0013
881 PYREXIA 456 0.0013
882 BLOOD GLUCOSE DECREASED 63 0.0013
883 EPILEPSY 40 0.0013
884 DRUG ADMINISTRATION ERROR 40 0.0013
885 LABORATORY TEST ABNORMAL 38 0.0013
886 HYPOACUSIS 55 0.0013
887 RESPIRATORY DISORDER 38 0.0013
888 DEVICE MALFUNCTION 89 0.0013
889 VISUAL ACUITY REDUCED 42 0.0013
890 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
891 GOUT 22 0.0012
892 INJECTION SITE WARMTH 25 0.0012
893 CARDIAC DISORDER 112 0.0012
894 HAEMOPTYSIS 33 0.0012
895 APPLICATION SITE ERYTHEMA 31 0.0012
896 WOUND 33 0.0012
897 ANAPHYLACTIC SHOCK 30 0.0012
898 PRURITUS GENERALISED 25 0.0012
899 DYSPNOEA EXERTIONAL 43 0.0011
900 HAEMORRHAGE 119 0.0011
901 CONJUNCTIVITIS 21 0.0011
902 EXTRAPYRAMIDAL DISORDER 28 0.0011
903 STEVENS-JOHNSON SYNDROME 25 0.0011
904 DELIRIUM 39 0.0011
905 HIP FRACTURE 36 0.0011
906 ARRHYTHMIA 53 0.0011
907 SKIN CANCER 24 0.0011
908 INJECTION SITE HAEMORRHAGE 89 0.0011
909 APPLICATION SITE PRURITUS 25 0.0011
910 ACUTE RESPIRATORY FAILURE 21 0.0011
911 OEDEMA PERIPHERAL 131 0.0011
912 INCORRECT DOSE ADMINISTERED BY DEVICE 28 0.0011
913 DEVICE LEAKAGE 46 0.0011
914 SEPSIS 118 0.0011
915 ATRIAL FIBRILLATION 103 0.0011
916 HEPATITIS 27 0.0011
917 INTENTIONAL DRUG MISUSE 22 0.0011
918 PANCREATITIS 55 0.0010
919 ACCIDENTAL EXPOSURE TO PRODUCT 107 0.0010
920 INJURY ASSOCIATED WITH DEVICE 21 0.0010
921 ANAEMIA 194 0.0010
922 ABASIA 25 0.0010
923 HYPOXIA 35 0.0010
924 LOWER RESPIRATORY TRACT INFECTION 45 0.0010
925 COMA 47 0.0010
926 CARDIOVASCULAR DISORDER 25 0.0010
927 OXYGEN SATURATION DECREASED 55 0.0010
928 MEDICATION ERROR 54 0.0010
929 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
930 HYPOGLYCAEMIA 47 0.0010
931 DEMENTIA 27 0.0010
932 HAEMATOMA 25 0.0010
933 HYPERGLYCAEMIA 35 0.0010
934 RECTAL HAEMORRHAGE 41 0.0010
935 LIVER DISORDER 42 0.0009
936 HYPOTENSION 187 0.0009
937 GENERAL PHYSICAL HEALTH DETERIORATION 105 0.0009
938 WHITE BLOOD CELL COUNT DECREASED 98 0.0009
939 CEREBROVASCULAR ACCIDENT 147 0.0009
940 RASH GENERALISED 22 0.0008
941 BLOOD CREATININE INCREASED 55 0.0008
942 LUNG DISORDER 41 0.0008
943 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
944 RENAL FAILURE 109 0.0008
945 ALANINE AMINOTRANSFERASE INCREASED 50 0.0008
946 ASPARTATE AMINOTRANSFERASE INCREASED 43 0.0008
947 ANGINA PECTORIS 23 0.0008
948 PRODUCT STORAGE ERROR 70 0.0008
949 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 37 0.0008
950 RHABDOMYOLYSIS 33 0.0008
951 ACUTE MYOCARDIAL INFARCTION 23 0.0008
952 BLOOD GLUCOSE INCREASED 146 0.0008
953 RENAL IMPAIRMENT 65 0.0008
954 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
955 DRUG DOSE OMISSION BY DEVICE 58 0.0007
956 NEUTROPHIL COUNT DECREASED 30 0.0007
957 LIVER FUNCTION TEST ABNORMAL 21 0.0007
958 BONE DENSITY DECREASED 22 0.0007
959 HAEMOGLOBIN DECREASED 72 0.0007
960 MYOCARDIAL INFARCTION 119 0.0007
961 CONVULSION 39 0.0007
962 FEMUR FRACTURE 21 0.0007
963 HAEMATURIA 22 0.0006
964 TOXICITY TO VARIOUS AGENTS 108 0.0006
965 PLATELET COUNT DECREASED 68 0.0006
966 ACUTE KIDNEY INJURY 97 0.0006
967 CARDIAC ARREST 52 0.0006
968 BREAST CANCER 58 0.0006
969 RESPIRATORY FAILURE 44 0.0006
970 FOETAL EXPOSURE DURING PREGNANCY 49 0.0006
971 SEPTIC SHOCK 26 0.0006
972 NEOPLASM MALIGNANT 39 0.0006
973 CARDIAC FAILURE CONGESTIVE 45 0.0006
974 LUNG NEOPLASM MALIGNANT 22 0.0005
975 DEVICE DIFFICULT TO USE 35 0.0005
976 BRADYCARDIA 28 0.0005
977 PULMONARY OEDEMA 23 0.0005
978 COMPLETED SUICIDE 42 0.0005
979 PLEURAL EFFUSION 30 0.0005
980 DEPENDENCE 27 0.0005
981 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
982 HYPONATRAEMIA 26 0.0005
983 DISEASE PROGRESSION 46 0.0004
984 CARDIAC FAILURE 21 0.0003
985 DEATH 222 0.0003
986 THROMBOCYTOPENIA 27 0.0002
987 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
988 NEUTROPENIA 21 0.0002